A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, critical role in dampening the immune system's response to cancer.
Apr 24, 2025
0
140
Researchers in Nikolaus Rajewsky's lab at Max Delbrück Center combined high-resolution, single-cell spatial technologies to map a tumor's cellular neighborhoods in 3D and identify potential targets for personalized cancer ...
Apr 24, 2025
0
1
Researchers at Baylor College of Medicine, Texas Children's Hospital, the Hospital for Sick Children in Toronto and collaborating institutions reveal in Nature Cell Biology a strategy that helps medulloblastoma, the most ...
Apr 23, 2025
0
24
A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, has identified a novel oncometabolite that accumulates in tumors and impairs immune cells' ability ...
Apr 21, 2025
0
43
Researchers have found that targeting an enzyme called PGM3 can help stop the growth of glioblastoma, the most dangerous type of brain tumor. Study findings are published online in the journal Science Advances.
Apr 18, 2025
0
19
High-intensity electrical pulses have been medically used to destroy tumors while sparing healthy tissue. But lower-intensity pulses may have a different effect—they reshape the battlefield, making tumors more vulnerable ...
Apr 17, 2025
0
146
The incidence of Human Papillomavirus (HPV)–associated oropharyngeal cancers—tumors of the back of the mouth and throat—is rising. If caught early, most of these cancers have a high survival rate, but about 20% of patients ...
Apr 17, 2025
0
83
Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.
Apr 15, 2025
0
12
Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years. One of the factors contributing to its aggressiveness is its tumor microenvironment, known as the ...
Apr 15, 2025
0
234
Researchers at Children's Hospital of Philadelphia (CHOP) developed a longitudinal atlas of neuroblastoma, a common and potentially deadly childhood cancer, to gain a deeper understanding into precise molecular mechanisms ...
Apr 14, 2025
0
6
